Human placental mesenchymal stem cells regulate inflammation via the NF‑κB signaling pathway

Liu,Youyi; Zhang,Xiading; Hu,Yiwei; Kang,Mingzhu; Wu,Yibo; Wang,Yuan; Deng,Chao

doi:10.3892/etm.2022.11591

Human placental mesenchymal stem cells regulate inflammation via the NF‑κB signaling pathway

Authors:
- Youyi Liu
- Xiading Zhang
- Yiwei Hu
- Mingzhu Kang
- Yibo Wu
- Yuan Wang
- Chao Deng
View Affiliations

Affiliations: Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu 214122, P.R. China, School of Pharmaceutical Science, Jiangnan University, Wuxi, Jiangsu 214122, P.R. China, Department of Obstetrics and Gynecology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu 214062, P.R. China
Published online on: September 7, 2022 https://doi.org/10.3892/etm.2022.11591
Article Number: 654
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Emerging evidence has indicated that mesenchymal stem cells (MSCs) are involved in the modulation of inflammation. Human placenta‑derived (HPL)‑MSCs exist in sufficient quantities and play a role in immune regulation. However, the exact roles of HPL‑MSCs in inflammation and the specific underlying mechanisms are not well defined. In the present study, HPL‑MSCs were obtained from human fetal placentas, and further purified using a commercial kit. Using ELISA, reverse transcription‑quantitative PCR, western blot, NO detection and other assays, the present study revealed that HPL‑MSCs may improve lipopolysaccharide‑induced macrophage inflammation by regulating macrophage polarization. Further mechanistic studies demonstrated that HPL‑MSCs attenuated the NF‑κB signaling pathway by regulating the expression of toll‑like receptor 4 and the phosphorylation of IκBα and p65, which resulted in a reduction in the levels of inflammation. The present study indicated that HPL‑MSCs may act as a novel target for the treatment of inflammation‑related diseases.

View Figures

View References

1	Liu YZ, Wang YX and Jiang CL: Inflammation: The common pathway of stress-related diseases. Front Hum Neurosci. 11(316)2017.PubMed/NCBI View Article : Google Scholar
2	Hao NB, Lu MH, Fan YH, Cao YL, Zhang ZR and Yang SM: Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol. 2012(948098)2012.PubMed/NCBI View Article : Google Scholar
3	Gordon S and Martinez FO: Alternative activation of macrophages: Mechanism and functions. Immunity. 32:593–604. 2010.PubMed/NCBI View Article : Google Scholar
4	Sica A and Mantovani A: Macrophage plasticity and polarization: In vivo veritas. J Clin Invest. 122:787–795. 2012.PubMed/NCBI View Article : Google Scholar
5	Orecchioni M, Ghosheh Y, Pramod AB and Ley K: Macrophage polarization: Different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front Immunol. 10(1084)2019.PubMed/NCBI View Article : Google Scholar
6	Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT and Sahebkar A: Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 233:6425–6440. 2018.PubMed/NCBI View Article : Google Scholar
7	Takeuchi O and Akira S: Pattern recognition receptors and inflammation. Cell. 140:805–820. 2010.PubMed/NCBI View Article : Google Scholar
8	Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A and Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677–686. 2004.PubMed/NCBI View Article : Google Scholar
9	Bluguermann C, Wu L, Petrigliano F, McAllister D, Miriuka S and Evseenko DA: Novel aspects of parenchymal-mesenchymal interactions: From cell types to molecules and beyond. Cell Biochem Funct. 31:271–280. 2013.PubMed/NCBI View Article : Google Scholar
10	Saleh M, Vaezi AA, Aliannejad R, Sohrabpour AA, Kiaei SZF, Shadnoush M, Siavashi V, Aghaghazvini L, Khoundabi B, Abdoli S, et al: Cell therapy in patients with COVID-19 using Wharton's jelly mesenchymal stem cells: A phase 1 clinical trial. Stem Cell Res Ther. 12(410)2021.PubMed/NCBI View Article : Google Scholar
11	Forbes GM, Sturm MJ, Leong RW, Sparrow MP, Segarajasingam D, Cummins AG, Phillips M and Herrmann RP: A Phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy. Clin Gastroenterol Hepatol. 12:64–71. 2014.PubMed/NCBI View Article : Google Scholar
12	Liang J, Zhang H, Hua B, Wang H, Lu L, Shi S, Hou Y, Zeng X, Gilkeson GS and Sun L: Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: A pilot clinical study. Ann Rheum Dis. 69:1423–1429. 2010.PubMed/NCBI View Article : Google Scholar
13	Liang L, Li Z, Ma T, Han Z, Du W, Geng J, Jia H, Zhao M, Wang J, Zhang B, et al: Transplantation of human placenta-derived mesenchymal stem cells alleviates critical limb ischemia in diabetic Nude rats. Cell Transplant. 26:45–61. 2017.PubMed/NCBI View Article : Google Scholar
14	Hu Y, Liao L, Wang Q, Ma L, Ma G, Jiang X and Zhao RC: Isolation and identification of mesenchymal stem cells from human fetal pancreas. J Lab Clin Med. 141:342–349. 2003.PubMed/NCBI View Article : Google Scholar
15	Tsai MS, Lee JL, Chang YJ and Hwang SM: Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod. 19:1450–1456. 2004.PubMed/NCBI View Article : Google Scholar
16	Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL and Chen TH: Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood. 103:1669–1675. 2004.PubMed/NCBI View Article : Google Scholar
17	Zhou B, Yuan J, Zhou Y, Ghawji M Jr, Deng YP, Lee AJ, Lee AJ, Nair U, Kang AH, Brand DD and Yoo TJ: Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis. Clin Immunol. 141:328–337. 2011.PubMed/NCBI View Article : Google Scholar
18	Xiang E, Han B, Zhang Q, Rao W, Wang Z, Chang C, Zhang Y, Tu C, Li C and Wu D: Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res Ther. 11(336)2020.PubMed/NCBI View Article : Google Scholar
19	Wu Q, Fang T, Lang H, Chen M, Shi P, Pang X and Qi G: Comparison of the proliferation, migration and angiogenic properties of human amniotic epithelial and mesenchymal stem cells and their effects on endothelial cells. Int J Mol Med. 39:918–926. 2017.PubMed/NCBI View Article : Google Scholar
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
21	Xie Z, Hao H, Tong C, Cheng Y, Liu J, Pang Y, Si Y, Guo Y, Zang L, Mu Y and Han W: Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats. Stem Cells. 34:627–639. 2016.PubMed/NCBI View Article : Google Scholar
22	Pelekanos RA, Sardesai VS, Futrega K, Lott WB, Kuhn M and Doran MR: Isolation and expansion of mesenchymal stem/stromal cells derived from human placenta tissue. J Vis Exp. (112)(54204)2016.PubMed/NCBI View Article : Google Scholar
23	Li JY, Ren KK, Zhang WJ, Xiao L, Wu HY, Liu QY, Ding T, Zhang XC, Nie WJ, Ke Y, et al: Human amniotic mesenchymal stem cells and their paracrine factors promote wound healing by inhibiting heat stress-induced skin cell apoptosis and enhancing their proliferation through activating PI3K/AKT signaling pathway. Stem Cell Res Ther. 10(247)2019.PubMed/NCBI View Article : Google Scholar
24	Biswas SK, Chittezhath M, Shalova IN and Lim JY: Macrophage polarization and plasticity in health and disease. Immunol Res. 53:11–24. 2012.PubMed/NCBI View Article : Google Scholar
25	Randolph GJ, Jakubzick C and Qu C: Antigen presentation by monocytes and monocyte-derived cells. Curr Opin Immunol. 20:52–60. 2008.PubMed/NCBI View Article : Google Scholar
26	Duffield JS: The inflammatory macrophage: A story of Jekyll and Hyde. Clin Sci (Lond). 104:27–38. 2003.PubMed/NCBI
27	Liu C, Li Y, Yu J, Feng L, Hou S, Liu Y, Guo M, Xie Y, Meng J, Zhang H, et al: Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil. PloS One. 8(e54841)2013.PubMed/NCBI View Article : Google Scholar
28	Bowdridge S and Gause WC: Regulation of alternative macrophage activation by chromatin remodeling. Nat Immunol. 11:879–881. 2010.PubMed/NCBI View Article : Google Scholar
29	Chen H, Sun H, You F, Sun W, Zhou X, Chen L, Yang J, Wang Y, Tang H, Guan Y, et al: Activation of STAT6 by sting is critical for antiviral innate immunity. Cell. 147:436–446. 2011.PubMed/NCBI View Article : Google Scholar
30	Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW and Chawla A: Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature. 447:1116–1120. 2007.PubMed/NCBI View Article : Google Scholar
31	Fujisaka S, Usui I, Kanatani Y, Ikutani M, Takasaki I, Tsuneyama K, Tabuchi Y, Bukhari A, Yamazaki Y, Suzuki H, et al: Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice. Endocrinology. 152:1789–1799. 2011.PubMed/NCBI View Article : Google Scholar
32	Kim J and Hematti P: Mesenchymal stem cell-educated macrophages: A novel type of alternatively activated macrophages. Exp Hematol. 37:1445–1453. 2009.PubMed/NCBI View Article : Google Scholar
33	Kwon JH, Kim M, Bae YK, Kim GH, Choi SJ, Oh W, Um S and Jin HJ: Decorin secreted by human umbilical cord blood-derived mesenchymal stem cells induces macrophage polarization via CD44 to repair hyperoxic lung injury. Int J Mol Sci. 20(4815)2019.PubMed/NCBI View Article : Google Scholar
34	Lu YC, Yeh WC and Ohashi PS: LPS/TLR4 signal transduction pathway. Cytokine. 42:145–151. 2008.PubMed/NCBI View Article : Google Scholar
35	Kollarova J, Cenk E, Schmutz C and Marko D: The mycotoxin alternariol suppresses lipopolysaccharide-induced inflammation in THP-1 derived macrophages targeting the NF-κB signalling pathway. Arch Toxicol. 92:3347–3358. 2018.PubMed/NCBI View Article : Google Scholar
36	Hoesel B and Schmid JA: The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 12(86)2013.PubMed/NCBI View Article : Google Scholar
37	Wesche DE, Lomas-Neira JL, Perl M, Chung CS and Ayala A: Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol. 78:325–337. 2005.PubMed/NCBI View Article : Google Scholar
38	Brown MA and Jones WK: NF-kappaB action in sepsis: The innate immune system and the heart. Front Biosci. 9:1201–1217. 2004.PubMed/NCBI View Article : Google Scholar
39	Liu Y, Liu L, Zhou Y, Zhou P, Yan Q, Chen X, Ding S and Zhu F: CKLF1 enhances inflammation-mediated carcinogenesis and prevents doxorubicin-induced apoptosis via IL6/STAT3 Signaling in HCC. Clin Cancer Res. 25:4141–4154. 2019.PubMed/NCBI View Article : Google Scholar
40	Isik A, Isik N and Kurnaz E: Complete breast autoamputation: Clinical image. Breast J. 26:2265–2266. 2020.PubMed/NCBI View Article : Google Scholar
41	Isik A, Soran A, Grasi A, Barry N and Sezgin E: Lymphedema after sentinel lymph node biopsy: Who is at Risk? Lymphat Res Biol. 20:160–163. 2022.PubMed/NCBI View Article : Google Scholar